L04AA Selective immunosuppressants

RX_L04AA

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AA

6989

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

5702

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

5702

diagram downward connector

Include endpoints None

5702

diagram downward connector
RX_L04AA

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 5702 3542 2160
Unadjusted prevalence (%) 1.60 1.79 1.37
Mean age at first event (years) 48.92 48.26 49.99

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.85 [2.21, 3.66] 4.9e-16 459
15 years 0.01 1.88 [1.44, 2.45] 3.1e-6 223
5 years 0.00 3.39 [2.54, 4.53] 1.3e-16 121
1 year 0.00 3.61 [2.26, 5.75] 6.9e-8 23

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_L04AA – L04AA Selective immunosuppressants
GWS hits:

Survival analyses between endpoints

Plot

before L04AA Selective immunosuppressants
after L04AA Selective immunosuppressants

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L04AA Selective immunosuppressants